Kimberly Chong

Array ( [id] => 4497655 [patent_doc_number] => 07947823 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-24 [patent_title] => 'siRNA expression system' [patent_app_type] => utility [patent_app_number] => 10/564020 [patent_app_country] => US [patent_app_date] => 2004-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 4964 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/947/07947823.pdf [firstpage_image] =>[orig_patent_app_number] => 10564020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7206422 [patent_doc_number] => 20050043264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Methods of inhibiting neurodegenerative disease' [patent_app_type] => utility [patent_app_number] => 10/883150 [patent_app_country] => US [patent_app_date] => 2004-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11958 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20050043264.pdf [firstpage_image] =>[orig_patent_app_number] => 10883150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 535195 [patent_doc_number] => 07173015 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-06 [patent_title] => 'Inhibition of Syk kinase expression' [patent_app_type] => utility [patent_app_number] => 10/880612 [patent_app_country] => US [patent_app_date] => 2004-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 5221 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/173/07173015.pdf [firstpage_image] =>[orig_patent_app_number] => 10880612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7097722 [patent_doc_number] => 20050130181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'RNA interference mediated inhibition of wingless gene expression using short interfering nucleic acid (siNA)' [patent_app_type] => utility [patent_app_number] => 10/881118 [patent_app_country] => US [patent_app_date] => 2004-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 59640 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20050130181.pdf [firstpage_image] =>[orig_patent_app_number] => 10881118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7202654 [patent_doc_number] => 20050042646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'RNA interference suppresion of neurodegenerative diseases and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/859751 [patent_app_country] => US [patent_app_date] => 2004-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 30497 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20050042646.pdf [firstpage_image] =>[orig_patent_app_number] => 10859751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7202612 [patent_doc_number] => 20050042641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'In vivo high throughput selection of RNAi probes' [patent_app_type] => utility [patent_app_number] => 10/854777 [patent_app_country] => US [patent_app_date] => 2004-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16116 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20050042641.pdf [firstpage_image] =>[orig_patent_app_number] => 10854777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9245548 [patent_doc_number] => 08609830 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-17 [patent_title] => 'Methods and compositions for RNA interference' [patent_app_type] => utility [patent_app_number] => 10/557219 [patent_app_country] => US [patent_app_date] => 2004-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 25 [patent_no_of_words] => 44569 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 228 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10557219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7138021 [patent_doc_number] => 20050182005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Anti-microRNA oligonucleotide molecules' [patent_app_type] => utility [patent_app_number] => 10/845057 [patent_app_country] => US [patent_app_date] => 2004-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9207 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20050182005.pdf [firstpage_image] =>[orig_patent_app_number] => 10845057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4634232 [patent_doc_number] => 08012681 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-06 [patent_title] => 'Methods of modulating metastasis and skeletal related events resulting from metastases' [patent_app_type] => utility [patent_app_number] => 10/556765 [patent_app_country] => US [patent_app_date] => 2004-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 25608 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/012/08012681.pdf [firstpage_image] =>[orig_patent_app_number] => 10556765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5085867 [patent_doc_number] => 20070275918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Induction of Cellular Senescence by Cdk4 Disruption for Tumor Suppression and Regression' [patent_app_type] => utility [patent_app_number] => 10/577591 [patent_app_country] => US [patent_app_date] => 2004-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 18261 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20070275918.pdf [firstpage_image] =>[orig_patent_app_number] => 10577591 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7264977 [patent_doc_number] => 20040242513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Tub antisense constructs' [patent_app_type] => new [patent_app_number] => 10/473411 [patent_app_country] => US [patent_app_date] => 2004-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9324 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242513.pdf [firstpage_image] =>[orig_patent_app_number] => 10473411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7117173 [patent_doc_number] => 20050070474 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Methods of treatment and compositions therefor' [patent_app_type] => utility [patent_app_number] => 10/835545 [patent_app_country] => US [patent_app_date] => 2004-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15803 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20050070474.pdf [firstpage_image] =>[orig_patent_app_number] => 10835545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7434514 [patent_doc_number] => 20040266714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Modulation of glucagon receptor expression' [patent_app_type] => new [patent_app_number] => 10/832777 [patent_app_country] => US [patent_app_date] => 2004-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31647 [patent_no_of_claims] => 127 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20040266714.pdf [firstpage_image] =>[orig_patent_app_number] => 10832777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 74709 [patent_doc_number] => 07750142 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-06 [patent_title] => 'Modulation of glucagon receptor expression' [patent_app_type] => utility [patent_app_number] => 10/832622 [patent_app_country] => US [patent_app_date] => 2004-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31490 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/750/07750142.pdf [firstpage_image] =>[orig_patent_app_number] => 10832622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7372007 [patent_doc_number] => 20040219151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Tetraspan protein and uses thereof' [patent_app_type] => new [patent_app_number] => 10/830942 [patent_app_country] => US [patent_app_date] => 2004-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 26890 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20040219151.pdf [firstpage_image] =>[orig_patent_app_number] => 10830942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7348073 [patent_doc_number] => 20040248174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Compositions and methods for siRNA inhibition of angiopoietin 1and 2 and their receptor Tie2' [patent_app_type] => new [patent_app_number] => 10/827759 [patent_app_country] => US [patent_app_date] => 2004-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13675 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248174.pdf [firstpage_image] =>[orig_patent_app_number] => 10827759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7466239 [patent_doc_number] => 20040198689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Expression systems for transcription of functional nucliec acid' [patent_app_type] => new [patent_app_number] => 10/820820 [patent_app_country] => US [patent_app_date] => 2004-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11603 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198689.pdf [firstpage_image] =>[orig_patent_app_number] => 10820820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7434484 [patent_doc_number] => 20040266712 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Selective inhibition of vascular smooth muscle cell proliferation' [patent_app_type] => new [patent_app_number] => 10/819500 [patent_app_country] => US [patent_app_date] => 2004-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8812 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20040266712.pdf [firstpage_image] =>[orig_patent_app_number] => 10819500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7154069 [patent_doc_number] => 20050026178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Allosteric probes and methods' [patent_app_type] => utility [patent_app_number] => 10/809886 [patent_app_country] => US [patent_app_date] => 2004-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9691 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20050026178.pdf [firstpage_image] =>[orig_patent_app_number] => 10809886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7050695 [patent_doc_number] => 20050186582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Compositions and methods of using hexokinase V' [patent_app_type] => utility [patent_app_number] => 10/805075 [patent_app_country] => US [patent_app_date] => 2004-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 25198 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20050186582.pdf [firstpage_image] =>[orig_patent_app_number] => 10805075 [rel_patent_id] =>[rel_patent_doc_number] =>)